Contineum Therapeutics, Inc. Class A Common Stock (CTNM NASDAQ) stock market data APIs
$13.8497
0.14(1%)
as of May 15, 2026
Try our APIs with
free plan!
Contineum Therapeutics, Inc. Class A Common Stock Financial Data Overview
Price chart is built with
Anychart
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company's lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.
Prev. Close
13.8497
Open
13.9927
High
14.1346
Low
13.3172
52 wk Range
3.35-16.33
Market Cap
531 M
Shares Outstanding
32 724 K
EPS
-0.39
Beta
0.888
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Contineum Therapeutics, Inc. Class A Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Contineum Therapeutics, Inc. Class A Common Stock data using free add-ons & libraries
Get Contineum Therapeutics, Inc. Class A Common Stock Fundamental Data
Contineum Therapeutics, Inc. Class A Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -66 527 248
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Contineum Therapeutics, Inc. Class A Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-14
- EPS/Forecast: -0.85
Get Contineum Therapeutics, Inc. Class A Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Contineum Therapeutics, Inc. Class A Common Stock News
New
Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus
Last week, the U.S. market performance was mixed, with gains from strong corporate earnings largely neutralized by slower growth expectations, rising inflation concerns and geopolitical tension. The t...
Is Contineum Therapeutics, Inc. (CTNM) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Contineum Therapeutics, Inc. (CTNM) is a stock that can certainly...
Cheap high flyer healthcare stocks - high momentum and low valuation
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As earnings season ramps up and geopolitical tensions keep affecting the mark...
Contineum Therapeutics announces proposed $75M public offering
* Contineum Therapeutics (NASDAQ:CTNM [https://seekingalpha.com/symbol/CTNM]) stated [https://seekingalpha.com/pr/20337545-contineum-therapeutics-announces-proposed-75_0-million-public-offering] on ...
Get Contineum Therapeutics, Inc. Class A Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
